Skip to content

The Impact of Anterior Abdominal Wall Tissue Oxygenation During Pneumoperitoneum of Regional Anesthesia Methods

Investigation the Effect of Regional Anesthesia Methods Anterior Abdominal Wall Tissue Oxygenation on Laparoscopic Cholecystectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03652506
Enrollment
90
Registered
2018-08-29
Start date
2018-08-28
Completion date
2018-12-28
Last updated
2018-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopy, Abdominal Wall, Regional Anesthesia

Brief summary

During laparoscopic surgery, the abdomen is inflated with carbon dioxide for abdominal imaging and increased intraabdominal pressure affects intraabdominal structures and abdominal wall.

Detailed description

The investigators aimed to investigate the effects of regional anesthesia methods administered during laparoscopic cholecystectomy on abdominal wall oxygenation and postoperative pain scores.

Interventions

DEVICEregional oxymetry probe

The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.

PROCEDUREQuadratus Lumborum block

Ultrasound guided unilateral anterior Quadratus Lumborum block with 20 ml %0.25 bupivacaine+The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.

Thoracic Epidural block with 20 ml %0.25 bupivacaine+The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.

Sponsors

Bursa Yuksek Ihtisas Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Masking description

Participant, Outcomes Assessor

Intervention model description

prospective,randomized

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients who were in the American Society of Anesthesiologists (ASA) I-III class * Underwent laparoscopic cholecystectomy

Exclusion criteria

* Previous surgeon surgeon * Local anesthetic allergy, * Bleeding is a diathesis disorder * Mental impairment, * Allergic to the drugs used, * Patients who are not reluctant to participate in the study, * Presence of infection in the block area, * Patients whose body mass index is over 30

Design outcomes

Primary

MeasureTime frameDescription
rso2peroperative 2 hoursThe regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line

Secondary

MeasureTime frameDescription
Visual Analog ScalePostoperative 24 hoursVisual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS). (0=no pain, 10=intolerable pain)
tramadol consumptionPostoperative 24 hourstramadol consumption with PCA (patient-controlled analgesia ) device
additional analgesic usePostoperative 24 hoursadditional analgesic use (paracetamol and NSAİD)

Contacts

Primary Contactkorgün Ökmen, M.D
korgunokmen@gmail.com05057081021
Backup ContactBurcu Metin Ökmen, M.D
burcumetinokmen@gmail.com05057081020

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026